Rodman & Renshaw Upgrades Biomea Fusion to Buy, Announces $18 Price Target
Portfolio Pulse from Benzinga Newsdesk
Rodman & Renshaw has upgraded Biomea Fusion (NASDAQ:BMEA) from Neutral to Buy, setting a price target of $18.
September 26, 2024 | 8:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Rodman & Renshaw has upgraded Biomea Fusion from Neutral to Buy, with a new price target of $18, indicating a positive outlook for the stock.
The upgrade from Neutral to Buy by Rodman & Renshaw, along with a specific price target of $18, suggests increased confidence in Biomea Fusion's future performance. Such analyst upgrades typically lead to positive short-term stock price movements as they can influence investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100